Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: A sequential, randomized, double-blind clinical trial
2007 ◽
Vol 29
(4)
◽
pp. 602-610
◽
2016 ◽
Vol 11
(1)
◽